nipah
viru
niv
member
genu
henipaviru
famili
paramyxovirida
caus
sever
often
lethal
respiratori
ill
enceph
human
high
mortal
rate
niv
caus
acut
lung
injuri
ali
human
humantohuman
transmiss
observ
recent
outbreak
niv
exact
rout
transmiss
human
known
previous
shown
niv
effici
infect
human
respiratori
epitheli
cell
molecular
mechan
nivassoci
ali
human
respiratori
tract
unknown
thu
urgent
need
model
henipaviru
infect
human
respiratori
tract
studi
pathogenesi
understand
host
respons
describ
novel
human
lung
xenograft
model
mice
studi
pathogenesi
niv
follow
transplant
human
fetal
lung
xenograft
rapidli
graft
develop
matur
structur
adult
lung
includ
cartilag
vascular
vessel
ciliat
pseudostratifi
columnar
epithelium
primit
air
space
fill
mucu
line
cuboid
flat
epithelium
follow
infect
niv
grow
high
titer
tcid
gram
lung
tissu
earli
day
post
infect
pi
niv
target
endothelium
well
respiratori
epithelium
human
lung
tissu
result
syncytia
format
niv
infect
human
lung
result
product
sever
cytokin
chemokin
includ
eotaxin
gcsf
gmcsf
day
pi
conclus
studi
demonstr
niv
replic
high
titer
novel
vivo
model
human
respiratori
tract
result
robust
inflammatori
respons
known
associ
ali
model
facilit
progress
fundament
understand
henipaviru
pathogenesi
virushost
interact
also
provid
biolog
relev
model
respiratori
virus
nipah
viru
niv
member
genu
henipaviru
famili
paramyxovirida
caus
sever
often
lethal
respiratori
ill
enceph
human
result
case
fatal
rate
first
human
case
niv
infect
identifi
outbreak
sever
febril
enceph
malaysia
singapor
recent
outbreak
occur
bangladesh
india
almost
yearli
sinc
niv
caus
acut
lung
injuri
ali
human
humantohuman
transmiss
observ
recent
outbreak
niv
data
histopatholog
lung
niv
case
limit
necropsi
find
respiratori
tract
niv
infect
case
includ
hemorrhag
necrosi
inflamm
epithelium
small
airway
bronchi
endotheli
cell
identifi
major
target
niv
studi
focus
role
endothelium
niv
pathogenesi
howev
limit
data
avail
host
respons
follow
niv
infect
human
lung
endothelium
play
import
role
termin
stage
niv
infect
role
respiratori
epithelium
earli
stage
infect
critic
howev
remain
larg
unexplor
specif
site
henipaviru
infect
human
respiratori
tract
still
unknown
well
molecular
mechan
virus
caus
diseas
human
previous
shown
niv
effici
infect
human
respiratori
epitheli
cell
trachea
bronchi
small
airway
result
induct
key
inflammatori
mediat
implic
leukocyt
recruit
ali
similarli
anim
model
hamster
ferret
african
green
monkey
niv
replic
high
titer
lung
anim
caus
acut
sever
respiratori
distress
human
xenograft
mous
model
previous
use
studi
tissu
develop
cancer
well
pathogenesi
infecti
agent
major
viral
pathogenesi
studi
involv
human
xenograft
mice
focu
human
immunodefici
viru
hiv
human
cytomegaloviru
hcmv
human
mice
graft
human
hematopoiet
stem
cell
thymu
report
first
character
niv
infect
human
respiratori
tract
use
human
lung
xenograft
model
gain
insight
mechan
niv
pathogenesi
human
result
show
niv
replic
high
titer
human
lung
infect
result
induct
robust
host
respons
sever
immunodefici
nsg
mice
serv
host
support
success
engraft
human
lung
xenograft
implant
small
fragment
human
fetal
lung
dorsal
subcutan
space
side
spine
follow
transplant
human
fetal
lung
xenograft
typic
increas
size
fold
month
human
fetal
lung
xenograft
rapidli
graft
develop
matur
structur
similar
seen
adult
lung
figur
matur
structur
includ
bronchi
partial
surround
cartilag
figur
line
ciliat
pseudostratifi
columnar
epithelium
figur
surround
longitudin
elast
fiber
bronchi
divid
bronchiol
termin
bronchiol
line
cuboid
flat
epithelium
figur
distal
respiratori
tract
compris
primit
alveolar
space
line
cell
flat
type
larger
round
type
pneumocyt
morpholog
figur
alveolar
wall
xenograft
thicker
normal
adult
human
lung
human
graft
well
vascular
presenc
arteri
vein
capillari
figur
final
express
pattern
ephrin
receptor
niv
similar
seen
normal
human
lung
tissu
figur
express
bronchial
epithelium
alveolar
cell
vasculatur
figur
natur
niv
infect
involv
exposur
viru
respiratori
epithelium
mimic
rout
human
lung
xenograft
lack
air
exchang
tissu
directli
inject
niv
follow
direct
intragraft
inject
lung
tissu
left
side
primari
infect
within
mous
nsg
mice
show
sign
morbid
mortal
observ
period
day
addit
two
nongraft
nsg
mice
challeng
intraderm
control
dose
xenograft
develop
clinic
sign
primari
infect
human
lung
xenograft
result
detect
infecti
niv
earli
day
post
infect
figur
niv
replic
high
titer
tcid
gram
tissu
day
post
infect
niv
titer
remain
high
end
experi
day
post
infect
importantli
high
titer
niv
also
detect
lung
tissu
right
side
mous
initi
infect
direct
intragraft
inject
earli
day
post
infect
find
clearli
demonstr
viru
spread
infect
human
lung
graft
uninfect
graft
mous
like
viremia
secondari
infect
figur
presenc
viremia
support
observ
infecti
niv
detect
albeit
lower
level
sever
mous
tissu
includ
lung
brain
heart
spleen
kidney
variou
time
point
post
infect
figur
fact
viremia
detect
blood
sampl
anim
day
post
infect
low
level
tcid
ml
infecti
niv
determin
tabl
interestingli
viru
detect
organ
nongraft
nsg
mice
challeng
intraderm
dose
tabl
suggest
nsg
mous
tissu
probabl
intrins
suscept
niv
order
confirm
human
lung
xenograft
could
infect
via
hematogen
rout
next
challeng
lungengraft
nsg
mice
niv
via
ip
rout
ip
challeng
niv
model
confirm
infect
result
detect
viremia
anim
viru
spread
human
lung
xenograft
replic
high
titer
result
histopatholog
chang
similar
observ
intragraft
challeng
tabl
togeth
data
suggest
follow
intragraft
infect
human
lung
highli
suscept
niv
infect
result
viremia
subsequ
spread
organ
absenc
diseas
order
studi
histopatholog
chang
associ
niv
infect
human
lung
tissu
section
stain
hematoxylin
eosin
h
e
gross
patholog
lesion
observ
human
lung
graft
sinc
nsg
mice
exhibit
multipl
defect
innat
adapt
immun
niv
infect
human
lung
graft
result
signific
inflamm
histopatholog
chang
human
lung
tissu
follow
niv
infect
independ
rout
infect
intragraft
indirect
intraperiton
includ
small
focal
area
syncytia
necrosi
earli
day
pi
figur
area
rapidli
expand
larg
area
hemorrhag
signific
loss
architectur
small
airway
day
pi
figur
main
histopatholog
featur
niv
infect
tissu
characterist
syncytia
format
figur
area
necrosi
figur
syncytia
format
could
observ
bronchial
epithelium
figur
alveolar
epithelium
figur
vascular
endothelium
figur
addit
fibrinoid
necrosi
observ
vasculatur
well
recruit
granulocyt
figur
agreement
absenc
clinic
sign
niv
infect
result
histopatholog
chang
viscer
mous
tissu
tabl
order
identifi
cell
target
niv
human
lung
viral
nucleocapsid
protein
n
express
human
lung
graft
examin
immunohistochemistri
express
niv
n
nipah
viru
niv
highli
pathogen
zoonot
viru
caus
fatal
diseas
human
varieti
mammalian
host
includ
pig
given
lack
effect
therapeut
vaccin
viru
consid
public
health
agricultur
concern
list
categori
c
prioriti
pathogen
biodefens
research
nation
institut
allergi
infecti
diseas
animaltohuman
humantohuman
transmiss
observ
studi
molecular
mechan
nivmedi
pathogenesi
hamper
lack
biolog
relev
vivo
model
studi
initi
host
respons
niv
infect
human
lung
show
new
small
anim
model
transplant
human
lung
tissu
studi
pathogenesi
niv
show
niv
replic
high
level
human
lung
niv
caus
extens
damag
lung
tissu
induc
import
regul
inflammatori
respons
studi
first
use
human
lung
transplant
studi
infecti
diseas
power
model
studi
pathogenesi
niv
infect
open
new
possibl
studi
virushost
interact
coincid
focal
area
histopatholog
chang
day
pi
show
intens
stain
figur
day
widespread
express
niv
n
observ
throughout
human
lung
tissu
figur
niv
primarili
target
respiratori
epithelium
bronchi
bronchiol
interstiti
mesenchym
cell
figur
small
airway
figur
cell
target
small
airway
primarili
cuboid
consist
pneumocyt
morpholog
although
cell
pneumocyt
morpholog
also
show
reactiv
addit
respiratori
epithelium
niv
replic
also
involv
vasculatur
figur
agreement
observ
low
level
infecti
viru
detect
sever
mous
tissu
small
focal
area
viral
antigen
primarili
focus
small
airway
epithelium
could
detect
mous
lung
figur
organ
test
tabl
tropism
viral
antigen
mous
lung
similar
tissu
infect
direct
inject
follow
ip
challeng
data
shown
although
focal
area
gener
center
around
vessel
figur
earli
stage
infect
niv
infect
involv
vasculatur
endotheli
cell
specif
target
infect
figur
similar
find
observ
anim
challeng
via
ip
rout
tabl
order
elucid
host
respons
follow
niv
infect
human
lung
express
sever
cytokin
chemokin
determin
homogen
human
lung
xenograft
follow
direct
infect
niv
figur
sinc
human
immun
cell
absent
model
express
human
cytokin
chemokin
primarili
result
niv
infect
human
epitheli
endotheli
cell
niv
infect
human
lung
result
express
sever
cytokin
chemokin
includ
gcsf
gmcsf
tnfa
vegf
start
day
pi
figur
express
gmcsf
tnfa
peak
day
post
infect
gradual
declin
time
express
peak
day
pi
wherea
gcsf
initi
peak
day
remain
high
throughout
infect
interestingli
vegf
express
continu
increas
time
concomit
increas
hemorrhag
remodel
lung
cytokin
chemokin
profil
similar
lung
xenograft
follow
primari
direct
secondari
indirect
infect
data
shown
nipah
viru
emerg
zoonot
viru
caus
sever
respiratori
distress
enceph
human
despit
intens
studi
vitro
anim
model
littl
known
studi
molecular
mechan
nivmedi
pathogenesi
hamper
lack
biolog
relev
vitro
model
studi
initi
host
respons
niv
infect
human
lung
fill
gap
recent
show
niv
effici
replic
primari
epitheli
cell
human
respiratori
tract
attract
model
studi
earli
step
niv
entri
host
lack
complex
microenviron
lung
current
model
show
human
fetal
lung
tissu
graft
immunocompromis
mous
develop
matur
human
lung
tissu
within
month
implant
transplant
lung
tissu
rapidli
vascular
develop
bronchiol
line
columnar
epithelium
alveolarlik
space
close
resembl
seen
normal
human
lung
tissu
prototyp
strain
niv
malaysia
use
studi
outbreak
malaysia
singapor
primarili
associ
develop
sever
febril
enceph
case
fatal
rate
respiratori
symptom
observ
lethal
case
interestingli
recent
outbreak
bangladesh
india
associ
higher
preval
respiratori
diseas
well
significantli
higher
case
fatal
rate
current
unknown
whether
differ
respiratori
involv
due
genet
differ
malaysia
bangladesh
strain
niv
whether
confound
factor
involv
howev
niv
strain
replic
effici
caus
respiratori
distress
anim
addit
histopatholog
data
avail
human
case
bangladesh
strain
niv
therefor
malaysia
strain
use
studi
allow
comparison
histopatholog
viral
tropism
human
vascul
fibrinoid
necrosi
lung
observ
major
fatal
case
niv
infect
multinucl
giant
cell
occasion
observ
alveolar
space
show
promin
immunostain
viral
antigen
along
alveolar
hemorrhag
edema
pneumonia
bronchial
epithelium
rare
show
histopatholog
chang
nipah
viral
antigen
could
also
observ
vasculatur
rare
bronchiolar
epithelium
believ
lack
viral
antigen
bronchial
epithelium
fatal
human
case
like
due
time
sampl
previous
show
use
hamster
model
bronchial
epithelium
initi
target
niv
earli
infect
follow
rapid
spread
interstitium
involv
pulmonari
vessel
present
model
niv
replic
high
titer
follow
intragraft
inject
viru
found
primarili
replic
respiratori
epithelium
bronchi
small
airway
consist
previou
find
human
respiratori
epithelium
highli
suscept
niv
infect
anim
nipah
viru
infect
human
lung
plo
pathogen
wwwplospathogensorg
model
lung
primari
target
organ
niv
infect
follow
intranas
challeng
addit
respiratori
epithelium
niv
replic
also
found
endothelium
type
cell
identifi
import
target
niv
infect
vascular
system
thought
occur
late
stage
diseas
lead
system
spread
virus
organ
includ
brain
kidney
model
system
spread
viru
indic
similar
titer
replic
kinet
niv
directli
inocul
lung
graft
graft
directli
inject
viru
suggest
follow
infect
lung
niv
quickli
becom
virem
spread
organ
addit
system
infect
intraperiton
inject
niv
also
result
infect
human
lung
graft
thu
confirm
hematogen
spread
viru
interestingli
niv
infect
nsg
mice
engraft
human
lung
tissu
result
clinic
sign
despit
evid
replic
mous
organ
includ
lung
brain
previou
studi
shown
niv
infect
type
ifn
receptor
knockout
mice
age
mice
lethal
age
mice
shown
mount
aberr
ifn
respons
nsg
mice
immunocompromis
mount
ifn
respons
seem
suffici
protect
lethal
diseas
studi
altern
possibl
nsg
mice
suscept
niv
viru
measur
mous
organ
found
blood
also
small
foci
viral
antigen
detect
mous
lung
could
correspond
emboli
infect
human
cell
slough
infect
graft
sever
cytokin
especi
vegf
upregul
niv
infect
human
lung
interestingli
level
cytokin
observ
xenograft
lung
model
similar
observ
lung
fatal
case
influenza
viru
upregul
inflammatori
mediat
tnfa
lung
previous
shown
play
role
pathogenesi
lethal
niv
hamster
well
develop
ali
respiratori
viru
infect
includ
sarscov
influenza
viru
vegf
import
role
ali
pathogenesi
act
growth
factor
increas
vascular
permeabl
previous
show
vegf
express
human
respiratori
epitheli
cell
niv
infect
suggest
vegf
may
partli
respons
increas
pulmonari
hemorrhag
endotheli
destruct
alveolar
remodel
emphysemalik
phenotyp
observ
model
sinc
inflammatori
mediat
also
play
import
role
recruit
immun
cell
data
suggest
inflamm
could
observ
model
human
immun
cell
present
addit
implant
human
lung
xenograft
nsg
mice
use
engraft
human
hematopoiet
system
studi
hematopoiesi
immun
inflammatori
diseas
humanspecif
pathogen
human
nsg
mous
model
routin
contain
human
cell
peripher
blood
week
post
engraft
hematopoiet
stem
cell
mani
inflammatori
mediat
express
current
studi
play
import
role
immun
cell
recruit
abil
engraft
human
immun
cell
allow
us
studi
effect
mediat
specif
immun
cell
popul
futur
studi
make
use
fulli
human
lung
xenograft
model
studi
role
inflammatori
respons
pathogenesi
differ
henipaviru
strain
human
lung
conclus
data
confirm
human
lung
highli
suscept
niv
infect
niv
capabl
replic
high
titer
human
lung
target
respiratori
epithelium
endothelium
infect
result
characterist
syncyti
format
extens
lung
damag
key
inflammatori
mediat
gcsf
gmcsf
express
infect
model
allow
detail
studi
pathogenesi
respiratori
diseas
caus
henipaviru
infect
furthermor
data
point
sever
inflammatori
mediat
potenti
play
critic
role
henipaviru
pathogenesi
may
valuabl
candid
futur
studi
mechan
henipaviru
pathogenesi
potenti
target
treatment
approv
anim
experi
obtain
institut
anim
care
use
committe
univers
texa
medic
branch
protocol
number
anim
work
perform
certifi
staff
associ
assess
accredit
laboratori
anim
care
aaalac
approv
facil
anim
hous
care
experiment
protocol
accord
nih
guidelin
offic
laboratori
anim
welfar
discard
tissu
deceas
human
fetus
obtain
via
nonprofit
partner
advanc
bioscienc
resourc
alameda
ca
approv
exempt
hh
regul
cfr
part
need
inform
consent
waiv
utmb
institut
review
board
niv
malaysia
strain
kindli
provid
special
pathogen
branch
center
diseas
control
prevent
atlanta
georgia
unit
state
viru
propag
vero
cell
dulbecco
minim
essenti
medium
supplement
fetal
calf
serum
hyclon
logan
ut
lglutamin
penicillin
streptomycin
humidifi
incub
infecti
work
perform
class
ii
biolog
safeti
cabinet
biosafeti
level
laboratori
galveston
nation
laboratori
human
lung
xenograft
mous
model
nodcgprkdcscid
mice
also
known
nodscidccnul
nsg
mice
jackson
laboratori
week
age
hous
steril
microisol
environ
mice
engraft
human
lung
tissu
advanc
bioscienc
resourc
alameda
ca
six
fragment
human
fetal
lung
donor
week
age
sutur
muscl
fascia
dorsal
subcutan
space
mous
cm
spine
three
side
anim
receiv
appropri
postsurgeri
treatment
includ
antibiot
analges
twelv
week
postengraft
anim
transfer
facil
prior
infect
anim
anesthet
chamber
induct
litersmin
isofluran
three
six
lung
tissu
inocul
via
intragraft
inject
tcid
niv
ml
volum
anim
monitor
daili
weight
loss
clinic
sign
group
anim
euthan
day
post
infect
sampl
viru
isol
histolog
examin
procur
whole
blood
edta
vacutain
human
lung
tissu
mous
liver
spleen
kidney
lung
heart
brain
separ
experi
anim
inject
via
intraperiton
rout
tcid
niv
euthan
day
post
infect
control
group
nsg
mice
without
lung
xenograft
challeng
via
intraderm
rout
tcid
niv
back
mous
locat
human
lung
xenograft
would
whole
blood
test
presenc
infecti
viru
diltut
describ
tissu
sampl
weigh
homogen
equival
volum
dmem
gener
solut
solut
centrifug
rpm
aerosol
contain
tabl
top
centrifug
min
pellet
insolubl
part
viru
titrat
perform
use
assay
plate
vero
cell
per
well
ml
inocula
clear
homogen
whole
blood
serial
dilut
plate
incub
day
well
score
cytopath
effect
cpe
viru
concentr
calcul
tcid
per
gram
tissu
tissu
sampl
immersionfix
neutral
buffer
formalin
least
day
condit
prior
remov
laboratori
formalin
chang
specimen
process
condit
convent
method
either
embed
paraffin
section
mm
thick
stain
hematoxylin
eosin
h
e
embed
tissu
tek
frozen
section
cut
mm
thick
use
immunofluoresc
stain
tissu
immunohistochemistri
ihc
stain
previous
describ
use
rabbit
antinivnucleoprotein
n
antibodi
kindli
provid
dr
c
broder
uniform
servic
univers
bethesda
md
tissu
stain
rabbit
antinivn
antibodi
biotinyl
ebiosci
anticollagen
iv
label
alexa
ebiosci
anti
ephrin
santa
cruz
biotechnolog
ephrin
r
system
hoechst
nuclear
stain
niv
n
mous
tissu
could
detect
follow
immunofluoresc
stain
like
due
limit
detect
convent
ihc
alexa
label
secondari
antibodi
life
technolog
use
detect
anti
niv
n
antibodi
well
anti
ephrin
antibodi
alexa
conjug
streptavidin
r
system
use
detect
antibodi
cytokinechemokin
concentr
homogen
niv
infect
human
lung
tissu
determin
use
milliplex
human
cytokin
premix
plex
immunoassay
kit
millipor
billerica
usa
prior
analysi
sampl
inactiv
dri
ice
gammaradi
mrad
assay
perform
accord
manufactur
instruct
concentr
follow
cytokin
determin
use
bioplex
system
biorad
epiderm
growth
factor
egf
granulocytecoloni
stimul
factor
gcsf
granulocyt
macrophagecoloni
stimul
factor
gmcsf
interferon
ifn
ifnc
interleukin
il
chemokin
ligand
chemokin
ligand
chemokin
ligand
chemokin
ligand
chemokin
ligand
tumor
necrosi
factor
tnfa
lymphotoxin
alpha
vascular
endotheli
growth
factor
vegf
